Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
The trans-isomer of clomiphene citrate, a SERM that stimulates endogenous testosterone production. Not a peptide, but widely used alongside peptide protocols for hormone optimization.
Verified purity per dollar — the cheapest that's actually been tested
No vendor for Enclomiphene currently meets our listing bar — every source we track is below a C trust grade, or doesn't have enough verified COA data yet. We'd rather show nothing than point you at one we can't stand behind.
Single-vial list prices by default for a fair head-to-head — switch to Multi-vial / bulk for pack pricing. Estimates only; verify at vendor before purchase. For research use only. Not medical advice.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Use the Full safety panel filter to require endotoxin, sterility, and heavy-metals testing on the current batch — not just HPLC purity.
Wiehle et al. (BJU Int 2013, PMID 23875626) established pharmacokinetics and demonstrated testosterone restoration to the normal range in men with secondary hypogonadism. Kaminetsky et al. (J Sex Med 2013, PMID 23530575) showed enclomiphene raised testosterone and sperm counts while testosterone gel suppressed gonadotropins and spermatogenesis. Phase 3 trials ZA-304 and ZA-305 (Kim et al., BJU Int 2016, PMID 26496621) confirmed efficacy in overweight/obese hypogonadal men with superior preservation of LH, FSH, and sperm counts versus AndroGel 1.62%. Despite these positive data, the FDA issued Complete Response Letters to Repros Therapeutics in 2014 and 2016; Androxal was never approved and Repros subsequently wound down. As of April 2026 no FDA-approved enclomiphene exists. It is dispensed off-label via 503A compounding pharmacies for secondary hypogonadism and post-TRT/HPTA restart.
This platform provides informational tools only, not medical advice.
Testosterone restoration using enclomiphene citrate in men with secondary hypogonadism: a pharmacodynamic and pharmacokinetic study (Wiehle et al., BJU Int)
2013
Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel (Kaminetsky et al., J Sex Med)
2013
Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement (Kim et al., BJU Int — Phase 3 ZA-304/ZA-305)
Prices verified as of July 2026. Actual prices may vary. For research use only.
2016
Disclosed Labs